-
Je něco špatně v tomto záznamu ?
Diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer
F. Fruhauf, D. Cibula, R. Kocian, M. Zikan, P. Dundr, J. Jarkovsky, D. Fischerova
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 2001-01-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2001-01-01 do Před 6 měsíci
PubMed
38950926
DOI
10.1136/ijgc-2024-005341
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- lymfadenektomie MeSH
- lymfatické metastázy * diagnostické zobrazování MeSH
- lymfatické uzliny * diagnostické zobrazování patologie chirurgie MeSH
- mikrometastázy diagnostické zobrazování MeSH
- nádory děložního čípku * diagnostické zobrazování patologie chirurgie MeSH
- předoperační péče metody MeSH
- retrospektivní studie MeSH
- senioři MeSH
- senzitivita a specificita MeSH
- ultrasonografie * metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: To assess the diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer, to compare the outcomes for pelvic and para-aortic regions, and to detect macrometastases and micrometastases separately. METHODS: Patients were retrospectively included if they met the following inclusion criteria: pathologically verified cervical cancer; ultrasonography performed by one of four experienced sonographers; surgical lymph node staging, at least in the pelvic region-sentinel lymph node biopsy or systematic pelvic lymphadenectomy or debulking. The final pathological examination was the reference standard. RESULTS: 390 patients met the inclusion criteria between 2009 and 2019. Pelvic node macrometastases (≥2 mm) were confirmed in 54 patients (13.8%), and micrometastases (≥0.2 mm and <2 mm) in another 21 patients (5.4%). Ultrasonography had sensitivity 72.2%, specificity 94.0%, and area under the curve (AUC) 0.831 to detect pelvic macrometastases, while sensitivity 53.3%, specificity 94.0%, and AUC 0.737 to detect both pelvic macrometastases and micrometastases (pN1). Ultrasonography failed to detect pelvic micrometastases, with sensitivity 19.2%, specificity 85.2%, and AUC 0.522. There was no significant impact of body mass index on diagnostic accuracy. Metastases in para-aortic nodes (macrometastases only) were confirmed in 16 of 71 patients who underwent para-aortic lymphadenectomy. Ultrasonography yielded sensitivity 56.3%, specificity 98.2%, and AUC 0.772 to identify para-aortic node macrometastases. CONCLUSION: Ultrasonography performed by an experienced sonographer can be considered a sufficient diagnostic tool for pre-operative assessment of lymph nodes in patients with cervical cancer, showing similar diagnostic accuracy in detection of pelvic macrometastases as reported for other imaging methods (18F-fluorodeoxyglucose positron emission tomography/CT or diffusion-weighted imaging/MRI). It had low sensitivity for detection of small-volume macrometastases (largest diameter <5 mm) and micrometastases. The accuracy of para-aortic assessment was comparable to that for pelvic lymph nodes, and assessment of the para-aortic region should be an inseparable part of the examination protocol.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019862
- 003
- CZ-PrNML
- 005
- 20241024111049.0
- 007
- ta
- 008
- 241015s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/ijgc-2024-005341 $2 doi
- 035 __
- $a (PubMed)38950926
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Fruhauf, Filip $u Department of Gynaecology, Obstetrics, and Neonatology, Gynaecologic Oncology Center, General University Hospital and 1st Faculty of Charles University, Prague, Czech Republic filip.fruhauf@vfn.cz $1 https://orcid.org/0000000241611890 $7 xx0207709
- 245 10
- $a Diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer / $c F. Fruhauf, D. Cibula, R. Kocian, M. Zikan, P. Dundr, J. Jarkovsky, D. Fischerova
- 520 9_
- $a OBJECTIVES: To assess the diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer, to compare the outcomes for pelvic and para-aortic regions, and to detect macrometastases and micrometastases separately. METHODS: Patients were retrospectively included if they met the following inclusion criteria: pathologically verified cervical cancer; ultrasonography performed by one of four experienced sonographers; surgical lymph node staging, at least in the pelvic region-sentinel lymph node biopsy or systematic pelvic lymphadenectomy or debulking. The final pathological examination was the reference standard. RESULTS: 390 patients met the inclusion criteria between 2009 and 2019. Pelvic node macrometastases (≥2 mm) were confirmed in 54 patients (13.8%), and micrometastases (≥0.2 mm and <2 mm) in another 21 patients (5.4%). Ultrasonography had sensitivity 72.2%, specificity 94.0%, and area under the curve (AUC) 0.831 to detect pelvic macrometastases, while sensitivity 53.3%, specificity 94.0%, and AUC 0.737 to detect both pelvic macrometastases and micrometastases (pN1). Ultrasonography failed to detect pelvic micrometastases, with sensitivity 19.2%, specificity 85.2%, and AUC 0.522. There was no significant impact of body mass index on diagnostic accuracy. Metastases in para-aortic nodes (macrometastases only) were confirmed in 16 of 71 patients who underwent para-aortic lymphadenectomy. Ultrasonography yielded sensitivity 56.3%, specificity 98.2%, and AUC 0.772 to identify para-aortic node macrometastases. CONCLUSION: Ultrasonography performed by an experienced sonographer can be considered a sufficient diagnostic tool for pre-operative assessment of lymph nodes in patients with cervical cancer, showing similar diagnostic accuracy in detection of pelvic macrometastases as reported for other imaging methods (18F-fluorodeoxyglucose positron emission tomography/CT or diffusion-weighted imaging/MRI). It had low sensitivity for detection of small-volume macrometastases (largest diameter <5 mm) and micrometastases. The accuracy of para-aortic assessment was comparable to that for pelvic lymph nodes, and assessment of the para-aortic region should be an inseparable part of the examination protocol.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a nádory děložního čípku $x diagnostické zobrazování $x patologie $x chirurgie $7 D002583
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a lymfatické uzliny $x diagnostické zobrazování $x patologie $x chirurgie $7 D008198
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a ultrasonografie $x metody $7 D014463
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a lymfatické metastázy $x diagnostické zobrazování $7 D008207
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a lymfadenektomie $7 D008197
- 650 _2
- $a předoperační péče $x metody $7 D011300
- 650 _2
- $a mikrometastázy $x diagnostické zobrazování $7 D061206
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cibula, David $u Department of Gynaecology, Obstetrics, and Neonatology, Gynaecologic Oncology Center, General University Hospital and 1st Faculty of Charles University, Prague, Czech Republic
- 700 1_
- $a Kocian, Roman $u Department of Gynaecology, Obstetrics, and Neonatology, Gynaecologic Oncology Center, General University Hospital and 1st Faculty of Charles University, Prague, Czech Republic
- 700 1_
- $a Zikan, Michal $u Department of Gynaecology and Obstetrics, Bulovka University Hospital and 1st Faculty of Charles University, Prague, Czech Republic
- 700 1_
- $a Dundr, Pavel $u Institute of Pathology, General University Hospital and 1st Faculty of Charles University, Prague, Czech Republic
- 700 1_
- $a Jarkovsky, Jiri $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Fischerova, Daniela $u Department of Gynaecology, Obstetrics, and Neonatology, Gynaecologic Oncology Center, General University Hospital and 1st Faculty of Charles University, Prague, Czech Republic $1 https://orcid.org/0000000272243218 $7 xx0074804
- 773 0_
- $w MED00009896 $t International journal of gynecological cancer : official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 34, č. 7 (2024), s. 985-992
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38950926 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111043 $b ABA008
- 999 __
- $a ok $b bmc $g 2202211 $s 1231835
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 34 $c 7 $d 985-992 $e 20240701 $i 1525-1438 $m International journal of gynecological cancer : official journal of the International Gynecological Cancer Society $n Int J Gynecol Cancer $x MED00009896
- LZP __
- $a Pubmed-20241015